ResMed
374 hedge funds and large institutions have $4.77B invested in ResMed in 2016 Q1 according to their latest regulatory filings, with 58 funds opening new positions, 156 increasing their positions, 107 reducing their positions, and 32 closing their positions.
81% more first-time investments, than exits
New positions opened: 58 | Existing positions closed: 32
46% more repeat investments, than reductions
Existing positions increased: 156 | Existing positions reduced: 107
8% more capital invested
Capital invested by funds: $4.44B → $4.77B (+$334M)
7% more funds holding
Funds holding: 351 → 374 (+23)
0.38% more ownership
Funds ownership: 59.32% → 59.7% (+0.38%)
3% less call options, than puts
Call options by funds: $6.84M | Put options by funds: $7.05M
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MICM
Matthews International Capital Management
San Francisco,
California
|
+$68.9M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$65.8M |
| 3 |
Capital World Investors
Los Angeles,
California
|
+$45.3M |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$35M |
| 5 |
CAM
Congress Asset Management
Boston,
Massachusetts
|
+$34.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$482M |
| 2 |
KI
Kalmar Investments
Greenville,
Delaware
|
-$27.7M |
| 3 |
WG
Winton Group
London,
United Kingdom
|
-$23.5M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$22.5M |
| 5 |
MAMU
Marathon Asset Management (UK)
London,
United Kingdom
|
-$15.5M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
401
Loomis, Sayles & Company
Boston,
Massachusetts
| – | -$64K | -1,199 | Closed |
|
|
MMG
402
Monetary Management Group
St Louis,
Missouri
| – | -$38K | -700 | Closed |
|
403
AssetMark Inc
Concord,
California
| – | -$26K | -481 | Closed |
|
|
VFA
404
Virtus Fund Advisers
Hartford,
Connecticut
| – | -$22K | -419 | Closed |
|
|
TRCT
405
Tower Research Capital (TRC)
New York
| – | -$11K | -200 | Closed |
|
RMD Hedge Fund Activity: Q1 2016 in Review
374 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in ResMed (RMD) for Q1 2016, worth a combined $4.77B — up 7.5% from $4.44B a quarter earlier.
Buyers outnumbered sellers: 58 funds opened new RMD positions and 32 closed out — a net gain of 26 holders — while 156 added to existing stakes and 107 trimmed.
The largest buyer was Matthews International Capital Management, adding an estimated $68.9M. The largest seller was Capital Research Global Investors, cutting an estimated $482M.
- 374 institutional investors held ResMed (RMD) as of Q1 2016, up from 351 in Q4 2015.
- Funds reported $4.77B of ResMed stock for Q1 2016, up 7.5% quarter-over-quarter.
- 58 funds opened new ResMed positions in Q1 2016 and 32 closed out, a net change of +26 holders.
- The largest ResMed buyer in Q1 2016 was Matthews International Capital Management, an estimated $68.9M added.
- The largest ResMed seller in Q1 2016 was Capital Research Global Investors, an estimated $482M sold.
Based on aggregated 13F filings for Q1 2016.